echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Rutai blood plug-ton softgel selected in "Cerebrovascular Disease Community Prevention and Control Guide"

    Rutai blood plug-ton softgel selected in "Cerebrovascular Disease Community Prevention and Control Guide"

    • Last Update: 2021-01-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    It is reported that the revision and preparation of the guide took nearly 2 years, bringing together a number of relevant experts, in the first edition of the "cerebrovascular disease community prevention and treatment guide" on the basis of the update in recent years on the high-risk groups of cerebrovascular disease and risk factors analysis, in the prevention of cerebrovascular disease, to provide more and more effective strategies and methods.
    the guidelines will provide guidance to community physicians on the prevention and treatment of cerebrovascular diseases, so that they can follow the rules in the prevention, first aid, rehabilitation, nursing and referral of cerebrovascular diseases, and improve their level of diagnosis and treatment.
    The acute injury period, injury and repair period of cerebral infarction are divided into sputum fever certificate, sputum wet certificate, gas false evidence, yin false evidence, according to the phased and typed treatment of the disease.
    can be injected with blood plugs during the period of injury and repair.
    Because blood clots throughout the various types are always common, so not listed as a single type, clinical treatment to reduce sugar, fat, antiplate plateboard aggregation of Western medicine as the basis, according to the characteristics of the type, can be added to the blood plug through softgels (each capsule containing three or seven total saponin 100mg).
    , pharmacological effects and methods of use of the softgels of Lyotai blood plug-in are described in detail in the clinical commonly used drug reference schedule.
    the past 70 years, Kun Medicine has been putting the promotion of chinese medicine heritage innovation and high-quality development in an important position, adhere to the combination of integrity and innovation, and actively expand the development direction of chinese medicine in the new era.
    as the leader of 37 innovative technology, the blood plug in the prevention and treatment of cardiovascular diseases played an important role.
    this time included in the guidelines, for primary doctors to manage cerebrovascular disease risk factors to provide a powerful tool to further promote the standardized management of cerebrovascular diseases at the grass-roots level, will also better promote the use of Chinese medicine in the management of primary chronic diseases.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.